1. Introduction {#sec0005}
===============

The management of patients with advanced gastric cancer requires a stable venous access required at different stages of disease (diagnostic phase, treatment phase, palliative phase) \[[@bib0005]\]. Totally implantable central venous access (Port) is often used for ensure safe infusions of chemotherapy or pain management and supportive care in cancer patients. Local and systemic complications may occur both during and after placement of port despite the well-established techniques for its placement and care.

Incidence and nature of complications of central venous catheter have been well established for long-term chemotherapy. However, very sparse data exists on the incidence of complications of molecularly targeted therapies administered through a totally implantable central venous access \[[@bib0010]\].

Retrospectively analyzing patients undergoing conventional chemotherapy, we report a case of a patient with results of extensive skin burns of the neck, chest and right arm and surgical outcomes of multiple skin grafts of chest to which a "PICC-PORT" was implanted in the left brachial vein \[[@bib0015], [@bib0020], [@bib0025], [@bib0030]\].

In this patient for the difficulty of implanting a port in the cervical-thoracic district, we recommend the totally subcutaneous implantation of the vascular device with peripheral access to the left arm, the PICC-PORT; other indications in our experience are head and neck cancer, patients with Radiodermatitis by radiation therapy for head and neck cancer, patients with ostomies (tracheobronchial/esophagus-ostomy), patients in molecular targeted therapy (EGFR-i), patients with severe kyphosis, patients with breast implants bilaterally, is added to the patient with extensive burns to the neck and chest or further skin grafts.

In Europe in recent years, for the availability of the vascular device of small dimensions and materials increasingly compatible, are implanting \"PICC-PORT\"; they are placed in the veins of the arm with ultrasound-guidance and the system appears to be free of early complications such as pneumothorax, arterial puncture, hematoma of the neck, pinch off syndrome \[[@bib0035]\].

This work has been reported in line with the SCARE criteria \[[@bib0040]\].

2. Presentation of case {#sec0010}
=======================

The patient is a 45-year-old man, in the November 2015 found during clinical-instrumental tests an advanced gastric cancer and subjected to Gastrectomy Subtotal with Billroth II reconstruction; in December 2015 comes to our observation in the DH of Oncology to undergo adjuvant chemotherapy. The oncologist, in anticipation of a combination chemotherapy with ECF (Epirubicin + Cisplatin + 5-FU), requires a stable central venous access for advanced disease.

Comes to our Vascular Access Ambulatory, the patient\'s medical examination showed the scars from a previous large burn of the neck, chest and right arm and surgical outcomes of multiple skin grafts chest ([Image 1](#img0005){ref-type="fig"}).Image 1Results of extensive skin burns of the neck, chest and right arm and surgical outcomes of multiple skin grafts of chest.Image 1

The difficulty of implanting a port in the cervical-thoracic district, we opt for the totally subcutaneous implantation of the vascular device in the left arm.

We performed an US of the left arm to assess the diameters of the brachial veins and basilica; it detects an internal brachial vein of good caliber 6,9 mm and you decide to implant a "PICC-PORT" (Images [2](#img0010){ref-type="fig"} and [3](#img0015){ref-type="fig"}).Image 2Ultrasound of arm veins; diameter of the brachial vein of the left arm.Image 2Image 3Type of port: Conventional Port and Picc-Port.Image 3

The device used for the plant was a Brachial Micro-Port 5 Fr, PUR, non-valved catheter, with hybrid reservoir (Titanium e Polyoxymethylene), in internal brachial vein left with ultrasound/ECG guidance ([Image 4](#img0020){ref-type="fig"}).Image 4Device 5 Fr used for placement of Picc-Port.Image 4

3. Discussion {#sec0015}
=============

The implantation of PICC-PORT was performed in patient with results of extensive skin burns of the chest; the catheter was placed in arm without skin burns; the vein of choice for US-guided puncture was the internal brachial. There were no early postoperative complications (hematoma, bleeding, displacements, rotations, detachment of the CVC from the reservoir) ([Image 5](#img0025){ref-type="fig"}).Image 5Post-procedural chest radiography.Image 5

The outcomes at 395 days (corresponds to the patient\'s death) after implantation is optimal, it was not complicated by thrombotic or infectious phenomena and the patient is satisfied in terms of aesthetic and social reintegration ([Image 6](#img0030){ref-type="fig"}).Image 6Picc-Port to the left arm, 365 days after implant.Image 6

4. Conclusion {#sec0020}
=============

The PICC-PORT is a Vascular Device, used in recent years, for the administration of Poly-Chemotherapies or Parenteral Nutrition (NP) or Chronic Pain Therapies; it is a device made up of a totally implantable brachial chamber and a central venous catheter in PUR (polyurethane) or SIL (silicone).

The PICC-PORT is positioned with the same technique as the PICC (ultrasound-guided vein puncture, with modified Seldinger technique and tip location with ECG technique); presents all the functional and aesthetic advantages of a totally subcutaneous device.

In the illustrated clinical case, the patient has extensive scars on the chest and neck, therefore the thoracic devices (chest Port, Tunneled venous catheter) cannot be implanted for thickened, inelastic skin, with a high risk of dehiscence of the surgical wound.

The case described is the first case in the scientific literature.

Implantation of the PICC-PORT is indicated in patient with head and neck cancer, patients with Radiodermatitis by radiation therapy for head and neck cancer, patients with ostomies (tracheobronchial/esophagus-ostomy), patients in molecular targeted therapy (EGFR-i), patients with severe kyphosis, patients with breast implants bilaterally, but with this case-report we can say even in patient with extensive burns to the neck, chest or further skin grafts.

The PICC-PORT is positioned in the veins of the arm with ultrasound-guidance and the system appears to be free of early complications such as pneumothorax, arterial puncture, hematoma of the neck, Pinch-off syndrome.
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